VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high… Read More
TORONTO, ON – Moderna announced it has received Health Canada approval, via a Supplemental New Drug Submission (SNDS), to manufacture its COVID-19 mRNA vaccine in Canada. The authorization allows end-to-end… Read More
Jump-started by a $22.5 million gift, UBC’s new AI and Health Network is deploying powerful artificial intelligence tools to drive health system innovation and improve patient care. Time is everything… Read More
Mid Yorkshire Teaching NHS Trust has been shortlisted for a HSJ Patient Safety Award recognising the Trust’s commitment to improving patient safety and driving innovation in healthcare. The Trust has… Read More
Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda®) Lexaria has now demonstrated, in distinct human clinical studies, clear reductions in AEs utilizing… Read More
